Fundies. English
Segment disclosures
Company overviewAutolus Therapeutics plc
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
3 dimension combinations 28 retained observations 9 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
License · Reportable Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:LicenseMember;us-gaap:StatementBusinessSegmentsAxis=autl:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 17000 | USD | 20260811 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 17000 | USD | 20260811 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 50000 | USD | 20251112 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 50000 | USD | 20251112 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260811 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260811 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251112 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 10091000 | USD | 20251112 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250812 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 10091000 | USD | 20250812 | Open filing evidence |
Product · Reportable Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=autl:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 45672000 | USD | 20260811 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 71890000 | USD | 20260811 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 21144000 | USD | 20251112 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 51049000 | USD | 20251112 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 20923000 | USD | 20260811 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 29905000 | USD | 20260811 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251112 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251112 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250812 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250812 | Open filing evidence |
Reportable Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=autl:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 45689000 | USD | 20260811 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 71907000 | USD | 20260811 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 26218000 | USD | 20260514 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 75388000 | USD | 20260327 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 20923000 | USD | 20260811 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 29905000 | USD | 20260811 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 8982000 | USD | 20260514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 10120000 | USD | 20260327 | Open filing evidence |